Global Cardiac Pacemaker Market Report: By Product Type(Implantable, External), By Technology Type(Single & Dual Chambered, Biventricular), By Region with COVID-19 impact | Forecast Period 2017-2030

Global Cardiac Pacemaker Market Outlook 2017-2030

Market Overview

The global cardiac pacemaker market is mainly driven owing to upsurge in cardiovascular diseases (CVD) majorly in developed and fast developing nations due to unhealthy diet, smoking, drug abuse, and excessive use of alcohol or caffeine, rise in geriatric population, worldwide. Further, given the trend towards a progressive ageing of populations, it is expected that the healthcare expenditure will continue to increase and will significantly aid the growth of cardiac pacemakers market. Through recent years, improvements in conventional technology and medical innovation have expanded the types and complexity of implantable devices to include such things as artificial hearts and deep-brain stimulators to control epilepsy. Further, the growing presence of chronic conditions, the number of patients who can benefit from implantable devices continues to grow. For instance, in United States heart disease is the leading cause of deaths. More than 600,000 Americans die of heart disease annually. That’s one in every four deaths in this country. Industry reports suggest that implantable device sales totaled about USD 43 billion in 2011 and are expected to grow to USD 74 billion in 2018. Such huge market for implantable devices shows the significant growth potential of cardiac pacemaker industry.

Goldstein Market Intelligence analyst forecast global Cardiac Pacemaker market is likely to thrive with the emergence of new technologies and surge in digitalization of medical procedures and demand for analytic solutions. Further, the Cardiac Pacemaker market is expected to expand at a CAGR of 7.1% over the forecast period and the major growth regions are likely to be the Europe and North America.

Global Cardiac Pacemaker Market Segmentation

By Product Type

• Implantable cardiac pacemaker
• External cardiac pacemaker

Based on type of product type, implantable cardiac pacemaker dominated the market with a share of around 70.0% in 2016 and the segment is anticipated to witness lucrative growth during the forecast period.

By Technology Type

• Single chambered
• Dual chambered
• Biventricular

By Geography

• North America (US, Canada) {Market Share (%), Market Size (USD Billion)} Cardiac Pacemaker Market
• Europe (UK, France, Italy, Germany, Spain, Sweden, Russia, Netherlands, Norway and Rest of Europe) {Market Share (%), Market Size (USD Billion)} Cardiac Pacemaker Market
• Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion)} Cardiac Pacemaker Market
• Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion)} Cardiac Pacemaker Market
• Asia Pacific (China, Japan, India, Singapore, South Korea, Australia and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion)} Cardiac Pacemaker Market

Based on geography, North America is expected to dominate the market followed by Europe during the forecast period. Dominance of North America is majorly attributed to the advanced healthcare infrastructure and dominance in global healthcare IT industry. Moreover, US will maintain its dominance in North America over the forecast period. Further, Asia Pacific region and other developing nations are likely to emerge as the area with maximum growth potential owing to focus of key players in emerging economies and improving healthcare infrastructure.

Covered In This Global Cardiac Pacemaker Market Report        

The report covers the present ground scenario and the future growth prospects of the cardiac pacemakers for 2017-2030 along with the market players’ analysis. We calculated the market size and revenue share on the basis of revenue generated from major players in all major regions. Global cardiac pacemaker market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players.

Global Cardiac Pacemaker Market Outlook 2017-2030, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global cardiac pacemaker market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. “Global Cardiac Pacemaker Market Report” also recognizes value chain analysis to understand the cost differentiation, pricing models to provide competitive advantage to the existing and new entry players.

COVID-19 impact on "Cardiac Pacemaker Market"

The report analyses and includes complete detailed chapter of 50-70 pages about the short term & long terms impact of COVID-19 outbreak on each segment of "Cardiac Pacemaker Market" along with government measures to support the sector. It also showcases the current market landscape during COVID, impact of the virus on leading companies, expected demand schedule and supply chain in the industry and other various major factors. This will help you identify those companies that may benefit from this pandemic as well as those that will lose out.

Top Companies in Competition & The Rising Stars

Our Global Cardiac Pacemaker Market Report comprises of the following companies as the key players:

• Abbott
• BIOTRONIK
• Boston Scientific
• Medtronic
• Cardiac Science
• CCC Medical Devices
• Cook Medical
• GE Healthcare
• MEDICO
• SORIN GROUP
• ZOLL Medical Corporation

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key Questions Answered In This Global Cardiac Pacemaker Market Report

• What is the total market size by 2030 and what would be the expected growth rate of market?
• What is the total revenue per segment and region in 2017-18 and what would be the expected revenue per segment and region over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for Cardiac Pacemaker Market
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the Cardiac Pacemaker Market’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects
• Insightful data on pacing industry along with competitive landscape